XML 138 R129.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

COMMITMENTS AND CONTINGENCIES - Narrative (Details) | Dec. 31, 2019 USD ($)
--- | ---
Other commitments |
Capital expenditures | $ 142,000,000
Milestone payments in terms of collaboration and license agreements, aggregate | 315,000,000
Spear Pharmaceuticals, Inc. And Spear Dermatology Products Inc. |
Other commitments |
Milestone payments in terms of collaboration and license agreements, aggregate | 70,000,000
Mitsubishi Tanabe Pharma Corporation |
Other commitments |
Milestone payments in terms of collaboration and license agreements, aggregate | 60,000,000
Novaliq GmbH |
Other commitments |
Milestone payments in terms of collaboration and license agreements, aggregate | 45,000,000
Kaken Pharmaceutical Co., Ltd. |
Other commitments |
Milestone payments in terms of collaboration and license agreements, aggregate | $ 43,000,000

X
- Definition Represents the amounts required to be paid by the reporting entity, which are contingent upon the achievement of specific development, regulatory or commercial milestones, in connection with the Collaboration Agreement. + References No definition available. + Details
Name: | bhc_CollaborativeAgreementMilestonePaymentsAggregate
Namespace Prefix: | bhc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | bhc_ScheduleOfCommitmentsLineItems
Namespace Prefix: | bhc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_CounterpartyNameAxis=bhc_SpearPharmaceuticalsInc.AndSpearDermatologyProductsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=bhc_MitsubishiTanabePharmaCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=bhc_NovaliqGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=bhc_KakenPharmaceuticalCo.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |